Biofarm Bucure
Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescr… Read more
Biofarm Bucure (BIO) - Total Liabilities
Latest total liabilities as of December 2025: RON85.86 Million RON
Based on the latest financial reports, Biofarm Bucure (BIO) has total liabilities worth RON85.86 Million RON as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biofarm Bucure - Total Liabilities Trend (2019–2025)
This chart illustrates how Biofarm Bucure's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Biofarm Bucure Competitors by Total Liabilities
The table below lists competitors of Biofarm Bucure ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hangzhou Hota M&E Holdings Co. Ltd. A
SHE:001225
|
China | CN¥164.63 Million |
|
Runa Smart Equipment Co. Ltd.
SHE:301129
|
China | CN¥434.52 Million |
|
Q-Free ASA
PINK:QFREF
|
USA | $557.12 Million |
|
Chengdu Dahongli Machinery Co Ltd
SHE:300865
|
China | CN¥207.01 Million |
|
Shanghai Rightongene Biotechnology Co. Ltd. A
SHG:688217
|
China | CN¥40.95 Million |
|
FIT Holding Co Ltd
TW:3712
|
Taiwan | NT$60.33 Billion |
|
Air Asia Co Ltd
TW:2630
|
Taiwan | NT$2.77 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Biofarm Bucure's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biofarm Bucure's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biofarm Bucure (2019–2025)
The table below shows the annual total liabilities of Biofarm Bucure from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | RON85.86 Million | +11.19% |
| 2024-09-30 | RON77.22 Million | +29.99% |
| 2023-09-30 | RON59.40 Million | -31.31% |
| 2022-09-30 | RON86.48 Million | +0.57% |
| 2021-09-30 | RON85.99 Million | +6.39% |
| 2020-09-30 | RON80.82 Million | -9.58% |
| 2019-09-30 | RON89.39 Million | -- |